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Abstract: A 34-year-old woman with no known medical history was evaluated for multiple painful brown nod-
ules and papules on the anterior aspect of the trunk. She mentioned a history of similar cutaneous findings on
her mother. Biopsies of three lesions revealed piloleiomyomata. Renal and adrenal ultrasound revealed an isolat-
ed simple cortical cyst, and pelvic and endovaginal ultrasound revealed two uterine myomata. The clinical diag-
nosis of hereditary leiomyomatosis and renal cell cancer was corroborated by the identification of a heterozygous
variant on exon 5 of the fumarate hydratase gene (c.578C>T p.T193I). Identification of the tumor piloleiomyoma
should alert the dermatologist to this rare genodermatosis, which is associated with an increased risk of renal cell
tumors, demanding multidisciplinary follow-up, and personal and family counseling.
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Resumo: Uma mulher de 34 anos sem antecedentes patológicos conhecidos foi avaliada por apresentar múltiplos
nódulos e pápulas castanhos, dolorosos, na face anterior do tronco. Referia história de achados cutâneos semelhan-
tes na sua mãe. As biópsias de três lesões revelaram piloleiomiomas. As ecografias renal e suprarenal identifica-
ram apenas cisto renal cortical simples, e as ecografias endovaginal e pélvica, dois miomas uterinos. O diagnósti-
co clínico de leiomiomatose herediária e câncer de células renais foi corroborado pela identificação de variante
heterozigota no exon 5 do gene da Fumarato hidratase (c.578C>T p.T193I). O piloleimomioma é um tumor cuja
identificação deve alertar o dermatologista para esta rara genodermatose, associada a um risco aumentado de
tumores de células renais, exigindo seguimento multidisciplinar e aconselhamento pessoal e familiar.
Palavras-chave: Carcinoma de células renais; Fumarato hidratase; Leiomioma; Leiomiomatose
Received on 15.01.2013.
Approved by the Advisory Board and accepted for publication on 14.02.2013.
* Work performed at the Dermatology Department, Santo António dos Capuchos Hospital - Centro Hospitalar de Lisboa Central, EPE – Lisbon, Portugal.
Conflict of interest: None
Financial funding: None
1 Degree in Medicine – Resident physician at the Dermatology/Venereology Department, Hospital de Santo António dos Capuchos - Centro Hospitalar de
Lisboa Central, EPE – Lisbon, Portugal.
2 Integrated Masters Degree in Medicine - Resident physician at the Dermatology/Venereology Department, Hospital de Santo António dos Capuchos - Centro
Hospitalar de Lisboa Central, EPE – Lisbon, Portugal.
3 Degree in Medicine  - Geneticist, Hospital de Dona Estefânea, Centro Hospitalar de Lisboa Central, EPE – Lisbon, Portugal.
4 Degree in Medicine  - Collaborating Assistant MD in Dermatology/Venereology in Department, Hospital de Santo António dos Capuchos, Centro Hospitalar
de Lisboa Central, EPE – Lisbon, Portugal.
©2013 by Anais Brasileiros de Dermatologia
s
INTRODUCTION
Hereditary leiomyomatosis and renal cell can-
cer (HLRCC) is thought to be a rare, autossomal dom-
inant cancer syndrome of incomplete penetrance,
caused by mutations of the fumarate hydratase gene
(FH) located on the 1q42.3-q43 region.1,2
Several synonyms for HLRCC exist such as:
multiple cutaneous and uterine leiomyomas 1 with or
without renal cell cancer (MCUL1), and Reed’s syn-
drome (cutaneous and uterine leiomyomatosis).1,3
HLRCC variably predisposes to: 1) cutaneous
leiomyomatosis; 2) uterine leiomyomatosis (rarely
with uterine leiomyosarcoma); and 3) an elevated risk
of malignant renal tumors.
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CASE REPORT
Patient 1, a 34-year- old woman with no previ-
ously known diseases, was evaluated for a long
course of multiple papules and small nodules of
brownish pink colour on the anterior aspect of the
upper body, painful either spontaneously or on expo-
sure to cold environments (Figure 1). In the past she
had two lesions excised, albeit non-cognizant of their
histological examination.
She denied any similar lesions on her immedi-
ate family, except for her mother who was also
observed (Figure 2). The 61-year-old mother had sim-
ilar lesions on her trunk and upper limbs and report-
ed a total histerectomy for symptomatic uterine
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myomatosis at age 38. They both recalled a history of
uterine myomatosis on the maternal grandmother.
Dermatoscopically, the lesions had a thin
brownish pink pigment network (Figure 3). Renal and
adrenal gland ultrasound identified a simple cortical
renal cyst with 20 mm diameter, and pelvic and
endovaginal ultrasounds two uterine myomas with 10
and 6 mm in patient 1. Cutaneous biopsies of three
lesions from patient 1 and two from the mother
revealed Piloleiomyomata (Figure 4 and 5).
A clinical diagnosis of HLRCC was made, cor-
roborated by the identification of a heterozygous vari-
ant on exon 5 of the Fumarate Hydratase gene
(c.578C>T p.T193I).
The patient decided to excise the symptomatic
lesions.
FIGURE 1: - Patient 1: Several brownish pink lesions on this patient’s
chest. Note recurrence of two lesions adjacent to scars belonging to
past excision of  lesions
FIGURE 3: - Patient 1: Brownish pink reticular pattern, with no other
local features except follicular ostia (image taken with Sony
Cybershot® DSC-T77 digital camera and Dermlite® II ProHr hand-
held dermoscope, 3Gen, LLC; original magnification × 10)
FIGURE 4: - Patient 1: Non encapsulated dermal tumor, with Grenz
zone and consisting of interlaced fibers of smooth muscle cells
(H&E × 40)
FIGURE 2: - Patient 2: Several lesions on the dorsum of 
the mother of the patient
FIGURE 5: - Patient 1: Interlaced fibers of smooth muscle cells, with
abundant eosinophilic cytoplasm and elongated nuclei with blunt
ends (H&E × 100)
with early metastasis even when smaller than 1 cm.1
Papillary RCC type 2 is the most frequent subtype, fol-
lowed by collecting duct RCC. When present, RCC is
typically solitary and unilateral.1,3,8 Renal cysts are also
more prevalent, in 36% patients versus 4.6% - 8.3% of
the general population.1
Although consensual criteria are lacking,
according to those proposed by Smit et al., our patient
met one major criterion (cutaneous leiomyomatosis)
and one minor criterion (first-degree relative treated
surgically for UL, under age 40).9 We also point to the
presence of multiple small leiomyomata and a cortical
renal cyst on our patient.
When the clinical and histopathological setting
is suggestive, direct gene sequencing of the FH codify-
ing region should be made.
Piloleiomyomata rarely demand treatment
except for cosmetic purposes or for pain relief, which
in most cases is tolerable. In isolated tumors surgery is
frequently resorted to. For pain relief in multiple
lesions, isolated or combination therapy with nitro-
glycerin, adrenergic receptor blockers, analgesics, anti-
depressants, cryotherapy or CO2 laser may be used.
3
In the follow-up and treatment of UL, the same
gynecologic recommendations available for the gener-
al population apply. Signs that suggest malignant
transformation may be screened for in gynecology.3
Currently there are no published guidelines for
the screening of RCC in HLRCC, although the main
therapeutic focus of this disease should be its early
detection. When a FH germline mutation is identified,
the patient and relatives should be subjected to adapt-
ed screening programs. Computerized tomography
(CT) at age 18 seems to us to be a reasonable course of
action, followed by ultrasound, or either CT or mag-
netic resonance for suspicious lesions. In the first case,
the surveillance interval can be annual or every 2
years. Even though RCC is rare during childhood, this
possibility should be considered in families with a his-
tory of RCC at a young age, with the screening test
adapted to the child’s age.10
Dermatological evaluation of patients with
HLRCC is mandatory. The histological confirmation
of cutaneous tumors selected by their typical clinical
appearance make the diagnosis easier, potentially
leading to prompt cancer detection in affected
patients and their families.q
DISCUSSION
Although cases compatible with HLRCC
already existed, the term Reed’s Syndrome appeared
after Reed et al recognized tumoral predisposition in a
family afflicted by multiple uterine (UL) and cuta-
neous leiomyomas (CL).1
Multiple heterozygous mutations of
the  FH gene were later identified, however with
unknown implications in the generation of the multi-
ple different phenotypes of this syndrome.4 In leiomy-
omatosis individuals, the presumed tumor suppressor
activity of the fumarate hydratase is reduced.1,2,3
The most prominent phenotypical characteris-
tic of HLRCC is the appearance of piloleiomyomas,
with presumable origin in the arrector pili muscle.
The number and size of these tumors can vary consid-
erably, giving rise to cutaneous settings that vary from
those that are practically unnoticeable to others that
are severe and extensive.1,3 The skin-colored, red or
brown papules or nodules occur in groups, scattered
or both, on the limbs, trunk or face. Typically they
cause pain on palpation or at low temperatures. There
is a low risk for skin leiomyosarcomas.3
Dermoscopically, CLs have not been extensive-
ly described in the literature. Judging by what has
been published, the findings are unspecific, varying
between structureless homogeneous areas and a thin
reticular pattern.5,6
The differential diagnosis should include: 1)
from a clinical point of view, angiolipoma, glomus
tumor and neurofibroma; and 2) histologically,
smooth muscle hamartoma, dermatomyofibroma and
dermatofibroma.7
ULs derived from the uterine smooth muscle
cells are common benign tumors even in healthy
women. In HLRCC, they are more frequent (79-100%
of cases), larger (up to 10 cm), more numerous (from 1
to 20), and appear at an earlier age (average of 30 ver-
sus 40 years in sporadic cases).1 Apart from menstrual
irregularity or associated pain, a growing number of
infertility cases have been reported. The association
with uterine leiomyosarcoma has been described as
very rare.1,8
Although only 20-25% of patients apparently
develop renal cell cancer (RCC), we prefer the term
HLRCC in order to highlight the importance of this
association.1,3 It is noteworthy that the majority of the
RCC in these patients is exceptionally aggressive,
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